Canada’s British Columbia province said on Wednesday it reached a C$150 million ($116.50 million) settlement with OxyContin maker Purdue Pharma Canada over healthcare costs related to the opioid crisis.
Purdue had been named as one of more than 40 defendants—drugmakers and distributors—in a proposed class-action lawsuit brought by British Columbia in 2018 on behalf of all provincial and federal Canadian governments. The lawsuit aims to recover healthcare costs for the “wrongful conduct of opioid manufacturers, distributors, and their consultants.”
“The proposed settlement with Purdue Canada has been agreed to by all federal, provincial, and territorial governments and totals C$150 million in monetary benefits, plus additional benefits including access to information and documents relevant to the lawsuit,” British Columbia said in a statement on Wednesday….